Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

  • Creating powerful possibilities for patients.

  • A Proven Leader in Women's Cancer Care

    As leaders in the world's fight to end women's cancers, the Susan F. Smith Center for Women's Cancers at Dana-Farber creates powerful possibilities for patients by bridging compassionate care and world-class research.

    Sara Tolaney, MD, MPH, and Alan D'Andrea, MD

    Sara Tolaney, MD, MPH, and Alan D'Andrea, MD

  • Make An Appointment

    Make An Appointment

    Get a Second Opinion

    Get a Second Opinion

    Call Us

  • Pioneering the Latest Advances

    Panos Konstantinopoulos, MD, PhD and Ursula Matulonis, MD

    Drug prolongs remissions in some relapsed ovarian cancers

    For women with relapsed ovarian cancer that responds to platinum-based chemotherapy, a drug that hampers cancer cells from repairing damaged DNA can significantly lengthen the period in which the disease is held in remission.

    Nikhil Wagle, MD

    A New Approach to Understanding Breast Cancer Treatment Resistance

    The information generated from this study has the potential to directly inform therapy choices for (ER)-positive patients.

    Judy Garber, MD, MPH

    The latest in genetics and women’s cancers

    In this Cancer Conversations podcast episode, Judy Garber, MD, MPH, discusses the latest in genetic research, including hereditary risks, genetic testing, and treatment options.


  • She told me it was going to be okay

    Erin and Dr. Partridge

    Erin - Breast cancer patient

    When Erin’s phone rang the night before her first visit to Dana-Farber’s Susan F. Smith Center for Women’s Cancers, she was surprised to hear the voice of the oncologist she would see the next day: Ann Partridge, MD, MPH.

    Read Erin's story